Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

被引：0
|
作者：
P L Nguyen
N E Martin
V Choeurng
B Palmer-Aronsten
T Kolisnik
C J Beard
P F Orio
M D Nezolosky
Y-W Chen
H Shin
E Davicioni
F Y Feng
机构：
[1] Dana-Farber/Brigham and Women’s Cancer Center and Harvard Medical School,Department of Radiation Oncology
[2] GenomeDx Biosciences,Department of Radiation Oncology
[3] University of California at San Francisco,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2017年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：186 / 192
页数：6
相关论文
共 50 条
  • [31] COST-MINIMIZATION ANALYSIS OF BIOPSY-BASED RISK STRATIFICATION TOOLS IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS BASED ON RESULTS FROM PHYSICIAN CASE STUDIES
    Zubek, V. B.
    Khan, F.
    Karvir, H.
    VALUE IN HEALTH, 2011, 14 (03) : A84 - A84
  • [32] Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and Prostate Cancer: An Episode-Based Analysis From 2015 to 2019
    Patel, Tej A.
    Jain, Bhav
    Vapiwala, Neha
    Chino, Fumiko
    Tringale, Kathryn R.
    Mahal, Brandon A.
    Yamoah, Kosj
    Mcbride, Sean N.
    Lam, Miranda B.
    Hubbard, Anne
    Nguyen, Paul L.
    Dee, Edward Christopher
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 119 (01): : 17 - 22
  • [33] Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study
    Kosakowska, Ewa
    Pietrzak, Lucyna
    Michalski, Wojciech
    Kepka, Lucyna
    Polkowski, Wojciech
    Jankiewicz, Malgorzata
    Cisel, Bogumila
    Krynski, Jacek
    Zwolinski, Jacek
    Wyrwicz, Lucjan
    Rutkowski, Andrzej
    Stylinski, Roman
    Nawrocki, Grzegorz
    Sopylo, Rafal
    Szczepkowski, Marek
    Tarnowski, Wieslaw
    Bujko, Krzysztof '
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2020, 25 (06) : 1017 - 1022
  • [34] A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
    Cullen, Jennifer
    Rosner, Inger L.
    Brand, Timothy C.
    Zhang, Nan
    Tsiatis, Athanasios C.
    Moncur, Joel
    Ali, Amina
    Chen, Yongmei
    Knezevic, Dejan
    Maddala, Tara
    Lawrence, H. Jeffrey
    Febbo, Phillip G.
    Srivastava, Shiv
    Sesterhenn, Isabell A.
    McLeod, David G.
    EUROPEAN UROLOGY, 2015, 68 (01) : 123 - 131
  • [35] Grade and stage misclassification in unfavorable intermediate vs high-risk NCCC prostate cancer candidates for RT plus short vs long-term androgen ADT
    Sorce, G.
    Flammia, R. S.
    Hoeh, B.
    Chierigo, F.
    Hohenhorst, L.
    Mazzone, E.
    Stabile, A.
    Gandaglia, G.
    Tian, Z.
    Tilki, D.
    Terrone, C.
    Gallucci, M.
    Chun, F. K. H.
    Saad, F.
    Shariat, S. F.
    Briganti, A.
    Montorsi, F.
    Karakiewicz, P., I
    EUROPEAN UROLOGY, 2022, 81 : S926 - S927
  • [36] Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991
    Bolla, Michel
    Maingon, Philippe
    Carrie, Christian
    Villa, Salvador
    Kitsios, Petros
    Poortmans, Philip M. P.
    Sundar, Santhanam
    van der Steen-Banasik, Elzbieta M.
    Armstrong, John
    Bosset, Jean-Francois
    Herrera, Fernanda G.
    Pieters, Bradley
    Slot, Annerie
    Bahl, Amit
    Ben-Yosef, Rahamim
    Boehmer, Dirk
    Scrase, Christopher
    Renard, Laurette
    Shash, Emad
    Coens, Corneel
    van den Bergh, Alphonsus C. M.
    Collette, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15) : 1748 - +
  • [37] REDEFINING HIGH-RISK PROSTATE CANCER BASED ON DISTANT METASTASES AND MORTALITY AFTER HIGH-DOSE RADIOTHERAPY WITH ANDROGEN DEPRIVATION THERAPY
    Tendulkar, Rahul D.
    Reddy, Chandana A.
    Stephans, Kevin L.
    Ciezki, Jay P.
    Klein, Eric A.
    Mahadevan, Arul
    Kupelian, Patrick A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04): : 1397 - 1404
  • [38] Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer
    Fecteau, Ryan E.
    Koontz, Bridget F.
    Hoffman, Karen E.
    Halabi, Susan
    Howard, Lauren E.
    Anand, Monika
    George, Daniel J.
    Zhang, Tian
    Berry, William R.
    Lee, W. Robert
    Harrison, Michael R.
    Corn, Paul G.
    Armstrong, Andrew J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024,
  • [39] Re: A Biopsy-Based 17-Gene Genomic Prostate Score Predicts Recurrence after Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low-and Intermediate-Risk Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2015, 193 (05): : 1541 - 1541
  • [40] Short-term Androgen Deprivation Decreases Distant Metastasis and Prostate Cancer-specific Mortality in Intermediate-risk Prostate Cancer Patients Undergoing Dose Escalated External Beam Radiation Therapy
    Zumsteg, Z. S.
    Spratt, D. E.
    Pei, X.
    Yamada, Y.
    Kalikstein, A.
    Kuk, D.
    Zhang, Z.
    Zelefsky, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S91 - S91
12345